ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626760 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626760; 2) Community: the network communities that were significantly associated with the response to NSC 626760; 3) Molecule: the relationships between components within communities and NSC 626760; 4) MDR: the compounds that were significantly associated with the NSC 626760.

NSC Compound Enrichment Correlation
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.0202245331784474 0.41205032
NSC 300288 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-[2-(dimethylamino)ethyl]-5-nitro- 0.0202245331784474 0.13677333
NSC 328403 Acetamide, N-(4-formyl-5,6,7,9-tetrahydro-1,2,3,10- tetramethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0202245331784474 0.21169316
NSC 3424 Acridine, 9-(4-[bis(2-chloroethyl)amino]-1-methylbutylamino)-6-chloro-2-methoxy-, dihydrochloride 0.0202245331784474 0.17355911
NSC 38087 Null 0.0202245331784474 0.24153611
NSC 382770 Null 0.0202245331784474 0.080214805
NSC 602613 Null 0.0202245331784474 0.20043319
NSC 623902 Null 0.0202245331784474 0.20686898
NSC 626167 Aplidazole C . TFA 0.0202245331784474 0.45067951
NSC 101003 Null 0.0202245331784477 0.27061317
Total:112  Current:50    [First] [Prev] [Next] [Last]